Page 1,237«..1020..1,2361,2371,2381,239..1,2501,260..»

Woman wounded in Las Vegas mass shooting dies after two years of treatment – The Independent

Posted: Published on November 20th, 2019

A woman who spent two years in a nursing facility recovering from spinal injuries she suffered in the deadliest mass shooting in modern US history has died. Kimberly Gervais could become the 59th fatality in the 2017 Las Vegas mass shooting, depending upon the coroners verdict Continue reading

Posted in MS Treatment | Comments Off on Woman wounded in Las Vegas mass shooting dies after two years of treatment – The Independent

MS Relief During Pregnancy Tied to Changes in T Cell Types – The Scientist

Posted: Published on November 20th, 2019

Autoimmune diseases tend to ease up during pregnancy, and for women with multiple sclerosis, physicians have documented fewer relapses of the condition while women are pregnant compared to before and after having a baby. Anecdotally, many MS patients also feel better when theyre expecting Continue reading

Posted in MS Treatment | Comments Off on MS Relief During Pregnancy Tied to Changes in T Cell Types – The Scientist

Opportunity for EMD Serono’s Mavenclad is Growing in the Relapsing-Remitting Multiple Sclerosis Segment of the Canada Market, Although Increasingly…

Posted: Published on November 20th, 2019

EXTON, Pa., Nov. 19, 2019 /PRNewswire/ -- Once approved by Health Canada and accessible on provincial drug formularies, the Canadian multiple sclerosis (MS) market is primed for swift adoption and solid uptake of Novartis' Mayzent, especially if granted a first-in-market unrestricted secondary progressive MS (SPMS) indication. Data from 50 neurologists surveyed in October for an ongoing twice-yearly report series included in Spherix's RealTime Dynamix: Multiple Sclerosis (Canada)service confirm that lack of approved therapies is the greatest obstacle to more expansive treatment of SPMS (whether active or not active) with disease-modifying therapies (DMTs) Continue reading

Posted in MS Treatment | Comments Off on Opportunity for EMD Serono’s Mavenclad is Growing in the Relapsing-Remitting Multiple Sclerosis Segment of the Canada Market, Although Increasingly…

This Could Be the Last Time – Multiple Sclerosis News Today

Posted: Published on November 20th, 2019

Fear grips me. Marijuana relaxes, eases pain, and helps my body work better. Continue reading

Posted in MS Treatment | Comments Off on This Could Be the Last Time – Multiple Sclerosis News Today

AVEO Oncology Announces Appointment of Scarlett Spring to its Board of Directors – BioSpace

Posted: Published on November 20th, 2019

It is a pleasure to welcome Scarlett to our Board of Directors, said Michael Bailey, president and chief executive officer of AVEO. Her experience and proven track record across a wide spectrum of roles within the industry will be of great value at this crucial juncture for AVEO Continue reading

Posted in MS Treatment | Comments Off on AVEO Oncology Announces Appointment of Scarlett Spring to its Board of Directors – BioSpace

Better HIV, lupus and hep C treatments possible with malaria discovery – Drug Target Review

Posted: Published on November 20th, 2019

A new discovery on how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus. In laboratory models, a research team has showed that strong inflammatory signals caused by malaria infection activate molecules that trigger the production of highly potent antibodies to fight the disease Continue reading

Posted in MS Treatment | Comments Off on Better HIV, lupus and hep C treatments possible with malaria discovery – Drug Target Review

Vascular biology Department of Surgery College of …

Posted: Published on November 19th, 2019

An expert team of University of Florida scientists, surgeons, engineers and mathematicians have worked together over the last 10 years to lay the foundation for a systems biology approach to further our understanding of vascular remodeling and vein bypass graft failure. Prior strategies have focused largely on linear models to separately describe the physical or biologic components of vascular disease progression Continue reading

Posted in Vascular Biology | Comments Off on Vascular biology Department of Surgery College of …

E-Cigarettes Take a Dangerous Toll on Heart Health – DocWire News

Posted: Published on November 19th, 2019

Electronic cigarette (e-cigarette) use negatively impacts heart disease risk factors such as cholesterol, triglycerides and blood sugar levels, according to new research being presented at the American Heart Associations Scientific Sessions 2019 taking place November 16-18 in Philadelphia. The findings are based on two separate studies. Continue reading

Posted in Vascular Biology | Comments Off on E-Cigarettes Take a Dangerous Toll on Heart Health – DocWire News

Another health warning for e-cigarette users that has nothing to do with lung disease – MarketWatch

Posted: Published on November 19th, 2019

Theres more evidence that e-cigarettes may be bad for your health. Continue reading

Posted in Vascular Biology | Comments Off on Another health warning for e-cigarette users that has nothing to do with lung disease – MarketWatch

Submerged Vegetation Mirrors Coast’s Health – Coastal Review Online

Posted: Published on November 19th, 2019

Scientists say studying submerged aquatic vegetation can provide clues to the coasts overall health. Continue reading

Posted in Vascular Biology | Comments Off on Submerged Vegetation Mirrors Coast’s Health – Coastal Review Online

Page 1,237«..1020..1,2361,2371,2381,239..1,2501,260..»